CA2140239C - Non-invasive testing - Google Patents
Non-invasive testing Download PDFInfo
- Publication number
- CA2140239C CA2140239C CA002140239A CA2140239A CA2140239C CA 2140239 C CA2140239 C CA 2140239C CA 002140239 A CA002140239 A CA 002140239A CA 2140239 A CA2140239 A CA 2140239A CA 2140239 C CA2140239 C CA 2140239C
- Authority
- CA
- Canada
- Prior art keywords
- detector units
- sample
- constituent
- spectrum
- detector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000012360 testing method Methods 0.000 title claims description 22
- 238000000034 method Methods 0.000 claims abstract description 54
- 239000000470 constituent Substances 0.000 claims abstract description 42
- 238000001228 spectrum Methods 0.000 claims abstract description 31
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 28
- 239000008103 glucose Substances 0.000 claims abstract description 28
- 238000001514 detection method Methods 0.000 claims abstract description 25
- 238000004458 analytical method Methods 0.000 claims abstract description 24
- 238000004737 colorimetric analysis Methods 0.000 claims abstract description 15
- 230000001537 neural effect Effects 0.000 claims abstract description 11
- 230000004438 eyesight Effects 0.000 claims abstract description 4
- 230000004044 response Effects 0.000 claims description 32
- 238000005259 measurement Methods 0.000 claims description 29
- 230000003595 spectral effect Effects 0.000 claims description 24
- 230000005855 radiation Effects 0.000 claims description 23
- 229940079593 drug Drugs 0.000 claims description 13
- 239000003814 drug Substances 0.000 claims description 13
- 238000013528 artificial neural network Methods 0.000 claims description 11
- 238000010521 absorption reaction Methods 0.000 claims description 10
- 230000036961 partial effect Effects 0.000 claims description 6
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 5
- 238000005286 illumination Methods 0.000 claims description 5
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 4
- 229910052710 silicon Inorganic materials 0.000 claims description 4
- 239000010703 silicon Substances 0.000 claims description 4
- 238000002834 transmittance Methods 0.000 claims 1
- 230000004456 color vision Effects 0.000 abstract description 13
- 210000004027 cell Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 230000005540 biological transmission Effects 0.000 description 7
- 238000002798 spectrophotometry method Methods 0.000 description 7
- 210000004556 brain Anatomy 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000005070 sampling Methods 0.000 description 5
- 208000030507 AIDS Diseases 0.000 description 4
- 208000003098 Ganglion Cysts Diseases 0.000 description 4
- 208000005400 Synovial Cyst Diseases 0.000 description 4
- 239000012491 analyte Substances 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 238000007405 data analysis Methods 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 210000001525 retina Anatomy 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 210000000411 amacrine cell Anatomy 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 238000002329 infrared spectrum Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 230000008447 perception Effects 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- 238000000862 absorption spectrum Methods 0.000 description 2
- 210000004958 brain cell Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 210000003754 fetus Anatomy 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 210000002287 horizontal cell Anatomy 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- GVGLGOZIDCSQPN-PVHGPHFFSA-N Heroin Chemical compound O([C@H]1[C@H](C=C[C@H]23)OC(C)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4OC(C)=O GVGLGOZIDCSQPN-PVHGPHFFSA-N 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000013473 artificial intelligence Methods 0.000 description 1
- 210000003050 axon Anatomy 0.000 description 1
- 229940125717 barbiturate Drugs 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 229960003920 cocaine Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000000205 computational method Methods 0.000 description 1
- 238000005094 computer simulation Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 210000001787 dendrite Anatomy 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229960002069 diamorphine Drugs 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000003400 hallucinatory effect Effects 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 230000010365 information processing Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000001328 optic nerve Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000002496 oximetry Methods 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 238000002106 pulse oximetry Methods 0.000 description 1
- 230000035485 pulse pressure Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000000985 reflectance spectrum Methods 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 210000000225 synapse Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000000411 transmission spectrum Methods 0.000 description 1
- 230000016776 visual perception Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
- G01N21/359—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light using near infrared light
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N21/4795—Scattering, i.e. diffuse reflection spatially resolved investigating of object in scattering medium
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N2021/3129—Determining multicomponents by multiwavelength light
- G01N2021/3137—Determining multicomponents by multiwavelength light with selection of wavelengths after the sample
Abstract
A new non-invasive detection method for glucose and other constituents of interest in a sample has been developed. The apparatus and methods of the invention provide an analog of color perception of human vision, preferably in the near infrared region, replacing the spectrophotometers used in other non-invasive near infrared detection methods. A plurality of detector units are used; each covering a broad region of the detected spectrum, paralleling color perception and colorimetry. In some circumstances, a neural net is used for analysis, allowing the system to learn. A novel method for background discrimination is also described.
Description
2140~3~9v ~~. t. WO 94!02837 - PCTlUS9310646y NON-ZNVAS_IVE TESTING
Backg_rgund of the Invention The present invention concerns the testing for constituents of interest using radiation, preferrably near infrared radiation. Fore particularly, an apparatus and a method of testing for constituents such as glucose, alcohol, drugs of abuse or other materials in a non-invasive manner have been developed. These methods are particularly well adapted for use in the home glucose testing - market'since they do not require a finger puncture to obtain a separable blood sample but rather can be:
utilized without bodily invasion.
Development of non-invasive testing method has become an important topic in the last several years. The spread of acquired immunodeficiency disease syndrome (AIDS), and the associated fear among public and healthcare personnel of AIDS has made many people of raid of invasive procedures. -"Invasive procedures," as used herein are procedures where a sample such as blood is taken from the body by puncture or other entry into the body before analysis, while non-invasive procedures do not require bodily penetration. Not only can diseases such as AIDS be spread with invasive procedures if proper precautions are not followed, hepatitis and other similar blood diseases are more common problems ;in this,type of testing. For example, a rece~,t article, "Nosocomiel transmission of Hepatitis B
virus associated with the use of a spring-loaded f finger-stick device, " ~v ~,ilg.~.and ~Qurnal ~ ~,e~ig~e_ ~ (11), 721-725 (1992), disclosed a mini-hepatitis epidemic in a hospital caused by the improper use of an instrument for taking blood samples. The nurses SUBSTITUTE SHEET
WO 94/Q2837 ~ PCT/US93~/Ob461 were unintentionally transmitting hepatitis from one patient to another with the sampling devise itself.
This type of disease transfer is eliminated with non-invasive testing.
The diabetic population has also been clamoring for non-invasive test instruments. Many diabetics must test their blood glucose..hevels four or more times a day. The modern battexy powered instruments for home use require a finger prick to obtain the sample: The extracted bland sample is then placed on a chemically treated carrier which is inserted into the instrument to obtain a glucose reading. This finger prick is painful and can be: a problem when required often. In addition, although the price has dropped considerably on these instruments, the cost for the disposables and the mess and health risks associated with having open bleeding is undesirable.
Accordingly, a number of groups have recently tried to make non-invas,~ve instruments for testing a variety of analytes, particularly glucose.
A recent trend in non-invasive testing has been to explore the use of the near infrared spectral region (700-1100 nm). This region contains the third overtones for the glucose spectrum and eliminates many of the water bands and othex inference bands that are potential problems for detection. However, this work has been carried out using classic spectrophotometric methods such as a set of narrow wavelength sources, or scanning spectrophotometers which scan wavelength by wavelength across a broad spectrum. The data obtained from these methods are SUBSTITUTE SHEET
spectra which then require substantial data processing to eliminate background; accordingly, the papers are replete with data analysis techniques utilized to glean the pertinent information.
Examples of this type of testing include the work by Clarke, fee United States Patent No. 5,054,487; and primarily the work by Rosenthal et al., see, e.g., United States Patent No. 5,028,787. Although the Clarke work uses reflectance spectra and the Rosenthal work uses primarily transmission spectra, both rely on obtaining near infrared spectrophotometric data.
One problem with using these types of methods is that spectrophotometers were conceived primarily for accurate determination in terms of wavelength, of the spectral structure, rather than for discriminating the presence of weak broadband features in strong broadband backgrounds. Since in non-invasive testing for glucose and other materials the primary information sought is the concentration, those using spectrophotometric methods here had to resort to using a number of unsatisfactory analysis techniques to suppress unwanted interferences and to calculate the amplitude of the signal.
The Rosenthal United States Patent No.
5,028,787 (the Rosenthal '787 Patent) illustrates this type of analysis technique for glucose testing using near infrared spectrophotometric methods.
First. a scan is made of 1/I vs. wavelength and the raw data is analyzed. Figure 1 of the present application is just such a plot, taken from the Rosenthal '787 Patent. Rosenthal takes the data developed from this scan and analyzes it using first WO 94/U2837 PGT/US93/06461 ~v ,. , 2~442~9 _ , and second derivative equations in an attempt to j obtain meaningful information. Additional patents and articles by Rosenthal, Cavinato, and others have used similar techniques for determinations'of levels of fat, ethanol, and other constituents of interest in a variety of samples.
However, all these techniques~'are dependent on the discrimination of the spectrophotometric data obtained. No form of data analysis can add to the initial information gathered; it can only put the measured information in a form which deemphasizes certain items of interference arising from the background or other constituents which make analysis of the sample difficult. A better solution to the problems of interference in broadband spectra is rather to obtain different raw data by measuring different aspects of the phenomenon.
As noted. Figure 1 is a plot of 1/z vs.
wavelength, taken using a scanning spectrophoto-meter. The scanning spectrophot meter takes a series r of discrete, single wavelength intensities and presents them as a function of time to obtain the spectrum. A plurality of high resolution features are necessary to obtain meaningful information.
However, the spectra of analytes of present interest do not include the large high resolution structures j of classical infrared spectroscopy but rather have a few low resolution features with much of the y' ~ information contained in the intensity. As such, these spectra appear more like the reflection spectra of colored objects in the visible region. A
detection device optimized for analysis of this type of spectra would provide better discrimination.
&UBSTITUTE SHEET
- 5 - :~
a Human vision is a incompetent spectrophoto- i meter but is superb at the subtlest color discrimination and identification even under greatly i varying illumination. The present invention measures or obtains the raw data in the infrared in a manner more similar to the way the eye performs in the visible, than classic spectrophotometric measurements. While visual perception is very complex and not completely understood, one approach suggested is the obtaining and processing of the raw data as closely as possible to the known aspects of color perception, utilizing a succession of steps or processing levels. Each step itself provides a useful product and succeeding steps represent products of greater capability.
The first step is the analog of colorimetry. Colorimetry is numerical color communication. This numeric approach uses three dimensions to describe the color. There presently are several such three dimensioz~rs spaces in use. One of these three dimensional spaces is the CTE 1931 (x, y)-chromaticity diagram (S~g Fig. 2). Luminosity, the third dimension, is not shown in Fig. 2. It is the trivariant nature of color vision that permits color to~be specified in a three dimensional space.
Another three dimensional space is represented in Figure 3. A plot is made of hue, :.
chroma and value and is shown as a three dimensional solid. These three numerical values can be used to specify any perceived color.
It is most important to note that although it is convenient to describe color in terms of a colorimetry, this is not color perception. Color SUBSTITUTE SHEET
iN0 94/02837 PCTIU$93/~6461 4 ~ , ._ ~1 perception is much more complex. However colorimetry is useful for color matching under s,~'ecific ,..
conditions. An analog of colorimetry, particularly ' one in the infrared region, would show similar .
usefulness in determining analyte.concentration.
There are commercially available colorimeters in the visible for measuring tristimulus y values in terms of luminosity, hue and saturation.
Briefly, these colorimeters use three detectors, with each detector input being filtered with a different filter function. Each of the filter functions is chosen to be similar to the three absorption spectra of the pigments of the three color receptive cones of the human retina. However, it appears no one has used, or even considered the use, of an analog of color perception for concentration measurements or even applied the method of colorimetry to infrared measurements as described herein.
Similarly, noninvasive measurement of arterial oxygen saturation by pua.se oximetry is widely acknowledged to be one of the most important technological advances in clinical patient , monitoring. Pulse oximeters measure differences in the visible and near infrared absorption spectra of ;
fully oxygenated and~reduced hemoglobin in arterial blood. Unlike clinical blood gas analyzers, which require a sample of blood from the patient and can only proqide intermittent measurement of patient oxygenation, pulse oximetry provide continuous, and instantaneous measurement of blood oxygen bevels.
~llBSTITUTE SHEET
-However, current commercial oximeters, and their algorithms are inaccurate under conditions of low pulse pressure and/or low oxygen saturation.
These severe conditions are observed in the normal unborn fetus. Unlike the transmission sampling of the commercial oaimeters. space limitations associated with the fetus require that the spectral data be obtained by reflectance sampling.
Reflectance sampling results in spectral data with a significantly lower signal-to-noise ratio than obtained with transmission sampling. It has been suggested that a new analysis technique using multivariate calibration methods can improve the precision, accuracy and reliability of quantitative spectral analysis. Even these techniques are limited by the type of input data.
Accordingly, an object to the invention is to provide an apparatus which provides an analog of colorimetric detection units so as to allow the measurements of the concentration of a constituent of interest.
Another object of the invention is to provide a method of measuring constituents of interest in a sample, preferably in a non-invasive manner, which is accurate, inexpensive and quick using an analog of a colorimetric analysis.
Another method of the invention is to provide a handheld instrument for glucose or drugs of abuse measurement based on the application of colorimetric type measurements to the near infrared region.
These and other objects and features will be apparent from the description and the accompanying drawings.
_ g _ Summarv of the Invention The present invention features an apparatus and method for the measurement of concentration of a constituent in a sample using reflectance or transmission, particularly in the near infrared. The apparatus and method of the present invention provide rapid, inexpensive measurements of high accuracy and are particularly adapted for non-invasive testing of the human body for constituents such as glucose or drugs of abuse.
In more detail, the invention provides an apparatus for measurement of the concentration of a constituent of interest which has absorbance or reflectance bands in the visible or near infrared spectrum. The constituent is in a sample which is illuminated by a light source that generates broad spectrum, preferably near infrared, radiation.
Although a single light source is preferred, in some embodiments multiple light sources can be used if the additive output of the light sources as a whole provides the requisite spectrum.
The apparatus also includes a sample chamber for holding the sample during measurement. The sample chamber can be arranged for non-invasive measurements of a portion of the human body such as a finger. The apparatus further includes detection means in the form of.a plurality of detector units.
Each detector unit is responsive to a specific region of the illuminating radiation or spectrum. Each of the detector units has at least partial non-parallel -_;.: W~ ~4/02~37 _ 214 p 2 3 9 PCT/US93/l16461 _ g _ overlapping regions of spectral response with at least one other of the detector units. In this manner, even in the region where the response of detector units overlap, each unit can provide some distinct information. The response from the detector units is the form of an output signal which is then transmitted to analysis means for combining and converting the output signal inta a measure of the concentration of the constituent of interest.
One key to the present invention is the realization that the detector units used should have a response to either transmitted or reflected radiation from the sample which is in a form of an analog of the color response of the eye. The response of the eye is in terms of red, green and blue sensors, the output of which are processed by the neural net in the eye and by the brain to provide the perception of color. The simplest approximation of color perception for certain specific conditions is colorimetry. A near infrareds analog of colorimetry, using infrared rather than visible radiation, is proposed herein, as are the use of colorimetry for concentration measurements and improved analysis methods. Accordingly, preferred embodiments of the invention have at least three detector units each having a spectral detection. range centered about a different portion of the selected spectrum but with response bands sufficiently wide that there is some overlap with at least one. and preferably more than one, other of the detector units. The detection means may also include a black/white or luminosity detector which is responsive to entire spectrum for which the other detector units have a spectral response. This SUBSTITUTE SHEET
~C3 94/02837 ~ ~ ~ PCT/US93/06461 ~' '°black/white" or luminosity detector, as used herein, is a detector like the other three that measures intensity of the signal photometrically in its spectral region of interest without perceiving the specificity of the wavelength,.~thereby showing the presence of a signal at one (or'',more) of the three other detectors.
The second step in complexity is to more closely approach color perception by using computational methods operating on the outputs of the detector units to emphasize the analyte with respect to the background. As a start, the computational models of color vision that have been developed in the field of "artificial intelligence" for attempting to achieve machine color vision will be utilized.
The third step towards approaching an analog of human color perception is to feed the detector unit outputs into an artificial neural net assembled similarly to the neural organization or circuitry of the retina and color portions in the brain. Here we expect to achieve learning for the detection, quantification, and in particular signal discrimination against background, with a smaller component cost and small size.
Neural networks, in the form of chips and other hardware, are presently available . Neural networks (or nets) provide processing which is similar to the brain (albeit on a less complicated scale) and, as such, can be "taught" to eliminate certain items of background.
The detector units can be selected to absorb only a particular broad band spectral region but more easily, standard silicon photocells can be used in conjunction with a series of broad bandpass filters.
SUBSTITUTE SHEET
. , W~ 94/0237 _ ~ 14 0 2 3 9 . PCT/US93/06461 i The term "broad bandpass infrared filters", as used herein, means filters that have a substantial half-width about a central wavelength, e.g., specified wavelengths in the near infrared region, so as to pass significant amounts of radiation far several hundred nm about the central wavelength. The use of broad bandpass filters allows significant response "tails" which overlap.
The apparatus can be adapted for detection of many substances. Preferred constituents of interest include glucose and drugs of abuse. "Drugs of abuse," as defined herein, include not just classic drugs of abuse such as marijuana, heroin,.
cocaine, amphetamines, barbiturates and other hallucinogenic or mind altering drugs, but also alcoho 1. For purposes of the invention, it does not matter whether the glucose or drug of abuse is measured directly but rather solely that the measurement of the sample can be correlated to the concentration of the constituent of interest. Far euample, it may be that the glucose is always correlated with the presence of a particular carrier or other indicating constituent and the carrier or constituent is measured in addition to and/or instead of the glucose itself.
The invention also features a method for measuring the concentration of a constituent of interest which absorbs or reflects light. The method has the steps of illuminating the sample with broadband spectrum, preferably near infrared, w radiation and detecting transmitted or reflected ;, .
iT ..
'a.
SUBSTITUTE SHEET
radiation from the sample. At least one signal corresponding to the detected radiation is generated and analyzed to determine the concentration of the constituent of interest. The detecting step of the method includes impinging radiation transmitted or reflected from the sample onto a detection array which includes a plurality of detector units each of which is responsive to a specific region of the near infrared spectrum. The specific spectral response from.each detector unit partially overlaps, in a non-parallel manner, the response from at least one other detector unit. Preferably, there are at least three detection units, each of which has a peak spectral response in a separate portion of the near infrared spectrum. The analysis step using this type of detection array allows analysis such that the output is formed into an analog of a colorimetric (e.g., tristimulus) value. The detector units may include broad bandpass filters to provide this spectral response and the detector array may also include a black/white detector unit such as has previously been described. In another aspect of the invention, the analysis may use an analog of a neural network, paralleling the working.of the eye and brain. This neural net based apparatus may even be used for classic colorimetry measurements.
The method of the invention is particularly well suited to non-invasive testing for constituent of the human body such as glucose, a glucose indicator or a drug of abuse. The finger is the preferred region for a sample for non-invasive testing.
;~'::'~'VO 94/02837 ~ i 4 0 2 3 9 . ' PCT/US93/06461 Another aspect of the invention is the use of paired detectors for referencing. In present non-invasive methods, there is na way to obtain a control reporting a "zero" concentration of the constituent of interest. However, by using a simulating filter o'r a filter made of the same material as the analyte but which has a concentration of the constituent of interest that is much higher than that in the sample, changing amounts of constituent in the sample merely cause a minor perturbation in the measurements from that "high concentration" reference detector. It may also be possible to use a material with substantially identical absorbance (or reflective) characteristics in place of the high concentration filter.
By using paired detectors with the "high concentration°' filter in front of one detector of the ' prior, one can obtain background measurements, unperturbed by the presence of the analyte to enhance discrimination. The term "paired detectors," as used herein means two or more detectors which are identical except for the high concentration filter.
For example, there could be paired red analog detectors, paired green analog detectors and paired v blue analog detectors, with the only difference being the addition of the high concentration filter to one of each pair. This type of high concentration filter is not limited to use with the apparatus and methods described'previously but has general applicability to any spectrophotometric system.
The following detailed description and the drawin will more clearl g y delineate the invention.
~;
;q :;
SUBSTITUTE SHEET
Wt? 94/02837 ~~~~t~ . .~ . PCf/US93/0646~
5...:' Brief Desrrip,~iQB of the Drawino Figure 1 is a spectrum for non-invasive glucose testing taken from United States Patent No.
5, 028, 787; ~.~'.;', Figure 2 is a CIE 1931 chromaticity plot;
Figure 3 is a three dimensional plot of color in terms of hue, chrome and value;
Figure 4 is a blue, green and red detector response vs. wavelength for a standard colorimeter, with a second scale of near infrared wavelengths as well as the visual wavelengths imposed on the X axis;
Figures 5A and 5B are variations of apparatus useful in the present invention; and Figure 6 is a detection array useful in the present invention.
Detailed Description of the Invention The present invention provides non-invasive procedures which can be used to test for glucose or other substances so long as the constituent of ' interest has absorption or reflectance bands in a selected, preferably,. near infrared, spectrum. The apparatus and methods of the invention are based in part, on the recognition that the present problems associated with attempting to conduct non-invasive measurements using near infrared radiation relate to ' the type of information which is obtained using spectrophotometers. Although using different analysis techniques can clarify what information has SUBSTITUTE SHEET
~...-r _ , . w ~' ~ . ,. , o~"., .~. . , , , .. .
_ a: WO 94/02837 _ 21 ~ ~ 2 ~ 9 PCT/U~93/Ob461 15 _ , been obtained, these analysis techniques cannot , generate optimum results if the underlying information obtained is itself not optimum. By J
applying an analog to colorimetry to concentration measurements , particularly forming a near infrared parallel of the three different pigments of the cones of the retina, significant information can be obtained which relates to concentration. Since in color perception "color constancy" is maintained under extreme variations in illumination, the use of neural~networks or digital computation to provide information in a manner more similar to the information processing of the eye-brain is preferred.
As noted previously, classic spectrophotometric methods for non-invasive measurements require the use of complex, and not altogether successful, data handling techniques in order to obtain meaningful information. Figure 1, which is a plot of wavelength versus 1/I intensity made using a scanning spectrophoi~ometer for a non-invasive determination of glucose. shows the problem with the classic techniques. First, the scan takes sufficient tame that there is the possibility of a change in the test conditions during the scan.
Second, while spectrophotometric measurements in the near infrared region are useful when there are high resolution features so that the substance of interest can be clearly discriminated from other substances, they do not work well unless the background and the features are separable. When glucose absorption bands are sought in the near infrared region, particularly using non-invasive techniques, only a SUBSTITUTE SHEET
few, low resolution features occur at the spectrum, such as that shown in Figure 1. This spectrum most resembles the spectrum of a colored object.
Figure 4 shows just such a color spectrum, with the red, green and blue detector responses of a colorimeter. The information determined from a colorimetric measurements is often used to determine the absolute color, and color differences of particular samples and their illuminants. Portable, inexpensive colorimeters are available in the market. For example, Minolta makes a series of tristimulus colorimeters including the Chroma meter xy-1 and Chroma meter CL-100. These tristimulus colorimeters may be used alone or attached to a data processor such as the Minolta DP-100 to express chromaticity readings in Yxy or Yu~v' systems, color difference readings in terms of G(Yxy) or ~(Yu'v').
luminescence, or black body temperature. These units can be used for either static or flickering light sources. Other instruments may be faster, i.e., give even more readings per second.
The Minolta colorimeters use silicon photocells which are filtered with red, green and blue broadpass filters. These filters cover a range from about 400-650 nm.
One aspect of the present invention utilizes this type of colorimeter with its filters replaced with filters having similar transmission and absorbance shapes but in the near infrared rather than visual region. 'The lower indices on the x-axis of Figure 4, those designated near infrared, can be used for guidelines for analogous transmission *Trade-mark spectra of filters for silicon photocells to obtain a spectral response in the near infrared rather than visual region. In this way, a near infrared equivalent to the tristimulus values could be constructed. With such information and sufficient standards, non-invasive measurements of constituent of interest such as glucose could be carried out in the near infrared region using substantially similar apparatus.
Figure 5A shows one type of apparatus particularly useful for non-invasive test of glucose using the methods of the present invention. A light source 10, which provides broad spectrum near infrared radiation (e.g., 700-1100 nm), is used for illumination. One possible light source is a tungsten-halogen bulb in a quartz envelope, filtered with a "heat shield" 20, if necessary, to provide only this wavelength range. A sample chamber 30 is shown for insertion of a finger or other bodily part if measurements are going to be made on a human or animal body. If a non-body sample is to be used, for ezample an agricultural sample, a different shaped sample chamber could be used in the same location.
The heat shield 20. which is optionally placed between lamp 10 and sample chamber 30, can be any material which will reduce the heat generated by the lamp 10 before if reaches sample chamber 30 without significantly degrading or absorbing the light generated from lamp 10 in its measurement region.
A detection array 40 is placed on the side of sample chamber 30 furthest from lamp 10 if a transmission mode is being utilized or off to the side of lamp 10 if a reflectance mode is being utilized.
WO 94I0~~37 PC'f/US93/0646j ~140~3~ -Source reference detectors 15 may be used to both measure the near infrared "color" of the source and guard against any changes in source output. In some embodiments. a paired detector array 40' and a special filter 50 may also°be used. Figure 5B shows the same apparatus as Figure 5A except the paired detectors are present. The illumination transmitted from sample chamber 30 goes to beam splitter 60 then either directly to detector array 40 or through filter 50 then to detector array 40'. Filter 50 is, preferably, a filter containing the same constituent of interest as is in the sample but in a concentration which is much (e.g., several order of.
magnitudes) higher. As such, filter 50 provides significant information concerning the background and the effective sample thickness since the amount of the constituent of interest in the sample acts merely as a negligible perturbation. This type of filter 50 is also useful for any other type of spectrophotometric analysis. The effective sample thickness or effective pathlength may also be corrected for by measuring the absorption of the sample in a wavelength region dominated by the absorption of the liquid carrier; e.g., water. The light reflected or transmitted from the sample is split into two output beams, a first output beam which is incident on a first detector responsive to the wavelength of the sample identifying bands, and the second'output beam which is incident on a second detector primarily responsive to liquid carrier absorption bands. This liquid carrier absorption .
measurement follows the same path as the sample indicating bands, yields an effective pathlength .
correction factor.
SUBSTITUTE SHEET
Figure 6 shows one type of detection array 40 which may be used in the present invention. This detection array has four detector units, three which are filtered in such a way that they have different peak spectral response but some partial overlap of spectral response while the fourth detector constitutes a black/white detector. This black/
white detector is responsive to all wavelengths in the infrared measurement region for which the other three detectors are responsive; that is, it generates an output signal responsive to wavelengths which cause a response for any of the three other detectors. As such, it acts like the rods of the retina of the eye.
The output from detector 40 (and detector 40' if used) is fed to analysis means 70. Analysis means 70 can be a computer, hardwired logic circuits, or a neural network. In any case, this analysis means 70 converts the output signal from the detectors to a measure of concentration.
Once the data from the detectors is obtained, it can be treated in a variety of ways. As noted previously, an analog of a colorimetric tristimulus value can be produced and calibrated against knowr. glucose concentrations. Problems that may arise with this simple type of data analysis is that calibration may be frequently required and may not be sufficiently universal, in that it will lack the analog of "color constancy" as do all colorimeters.
W~ 94/2837 . PCT/US93/06461 ~~~~,~~ - ~o -l3owever, the data analysis from the system, can be improved to more closely approach color .
perception by digital computation or with the use of neural networks (neural nets). While artificial-neural networks usually contain hundreds of interconnected neurons, this analog of color perception may only require about two dozen.
What this artificial neural act attempts to simulate are:
1. The horizontal cells, which transmit signals horizontally from the rods and cones to the bipolar cells.
2. The bipolar cells which transmit signals from the rods, cones and horizontal cells to synapse with either amacrine cells or ganglion cells.
3. The amacrine cells which transmit signals in two directions, either directly from bipolar cells to ganglion cells or horizontally among the axons of the bipolar cells, the dendrites of the ganglion cells, and/or other amacrine cells.
Backg_rgund of the Invention The present invention concerns the testing for constituents of interest using radiation, preferrably near infrared radiation. Fore particularly, an apparatus and a method of testing for constituents such as glucose, alcohol, drugs of abuse or other materials in a non-invasive manner have been developed. These methods are particularly well adapted for use in the home glucose testing - market'since they do not require a finger puncture to obtain a separable blood sample but rather can be:
utilized without bodily invasion.
Development of non-invasive testing method has become an important topic in the last several years. The spread of acquired immunodeficiency disease syndrome (AIDS), and the associated fear among public and healthcare personnel of AIDS has made many people of raid of invasive procedures. -"Invasive procedures," as used herein are procedures where a sample such as blood is taken from the body by puncture or other entry into the body before analysis, while non-invasive procedures do not require bodily penetration. Not only can diseases such as AIDS be spread with invasive procedures if proper precautions are not followed, hepatitis and other similar blood diseases are more common problems ;in this,type of testing. For example, a rece~,t article, "Nosocomiel transmission of Hepatitis B
virus associated with the use of a spring-loaded f finger-stick device, " ~v ~,ilg.~.and ~Qurnal ~ ~,e~ig~e_ ~ (11), 721-725 (1992), disclosed a mini-hepatitis epidemic in a hospital caused by the improper use of an instrument for taking blood samples. The nurses SUBSTITUTE SHEET
WO 94/Q2837 ~ PCT/US93~/Ob461 were unintentionally transmitting hepatitis from one patient to another with the sampling devise itself.
This type of disease transfer is eliminated with non-invasive testing.
The diabetic population has also been clamoring for non-invasive test instruments. Many diabetics must test their blood glucose..hevels four or more times a day. The modern battexy powered instruments for home use require a finger prick to obtain the sample: The extracted bland sample is then placed on a chemically treated carrier which is inserted into the instrument to obtain a glucose reading. This finger prick is painful and can be: a problem when required often. In addition, although the price has dropped considerably on these instruments, the cost for the disposables and the mess and health risks associated with having open bleeding is undesirable.
Accordingly, a number of groups have recently tried to make non-invas,~ve instruments for testing a variety of analytes, particularly glucose.
A recent trend in non-invasive testing has been to explore the use of the near infrared spectral region (700-1100 nm). This region contains the third overtones for the glucose spectrum and eliminates many of the water bands and othex inference bands that are potential problems for detection. However, this work has been carried out using classic spectrophotometric methods such as a set of narrow wavelength sources, or scanning spectrophotometers which scan wavelength by wavelength across a broad spectrum. The data obtained from these methods are SUBSTITUTE SHEET
spectra which then require substantial data processing to eliminate background; accordingly, the papers are replete with data analysis techniques utilized to glean the pertinent information.
Examples of this type of testing include the work by Clarke, fee United States Patent No. 5,054,487; and primarily the work by Rosenthal et al., see, e.g., United States Patent No. 5,028,787. Although the Clarke work uses reflectance spectra and the Rosenthal work uses primarily transmission spectra, both rely on obtaining near infrared spectrophotometric data.
One problem with using these types of methods is that spectrophotometers were conceived primarily for accurate determination in terms of wavelength, of the spectral structure, rather than for discriminating the presence of weak broadband features in strong broadband backgrounds. Since in non-invasive testing for glucose and other materials the primary information sought is the concentration, those using spectrophotometric methods here had to resort to using a number of unsatisfactory analysis techniques to suppress unwanted interferences and to calculate the amplitude of the signal.
The Rosenthal United States Patent No.
5,028,787 (the Rosenthal '787 Patent) illustrates this type of analysis technique for glucose testing using near infrared spectrophotometric methods.
First. a scan is made of 1/I vs. wavelength and the raw data is analyzed. Figure 1 of the present application is just such a plot, taken from the Rosenthal '787 Patent. Rosenthal takes the data developed from this scan and analyzes it using first WO 94/U2837 PGT/US93/06461 ~v ,. , 2~442~9 _ , and second derivative equations in an attempt to j obtain meaningful information. Additional patents and articles by Rosenthal, Cavinato, and others have used similar techniques for determinations'of levels of fat, ethanol, and other constituents of interest in a variety of samples.
However, all these techniques~'are dependent on the discrimination of the spectrophotometric data obtained. No form of data analysis can add to the initial information gathered; it can only put the measured information in a form which deemphasizes certain items of interference arising from the background or other constituents which make analysis of the sample difficult. A better solution to the problems of interference in broadband spectra is rather to obtain different raw data by measuring different aspects of the phenomenon.
As noted. Figure 1 is a plot of 1/z vs.
wavelength, taken using a scanning spectrophoto-meter. The scanning spectrophot meter takes a series r of discrete, single wavelength intensities and presents them as a function of time to obtain the spectrum. A plurality of high resolution features are necessary to obtain meaningful information.
However, the spectra of analytes of present interest do not include the large high resolution structures j of classical infrared spectroscopy but rather have a few low resolution features with much of the y' ~ information contained in the intensity. As such, these spectra appear more like the reflection spectra of colored objects in the visible region. A
detection device optimized for analysis of this type of spectra would provide better discrimination.
&UBSTITUTE SHEET
- 5 - :~
a Human vision is a incompetent spectrophoto- i meter but is superb at the subtlest color discrimination and identification even under greatly i varying illumination. The present invention measures or obtains the raw data in the infrared in a manner more similar to the way the eye performs in the visible, than classic spectrophotometric measurements. While visual perception is very complex and not completely understood, one approach suggested is the obtaining and processing of the raw data as closely as possible to the known aspects of color perception, utilizing a succession of steps or processing levels. Each step itself provides a useful product and succeeding steps represent products of greater capability.
The first step is the analog of colorimetry. Colorimetry is numerical color communication. This numeric approach uses three dimensions to describe the color. There presently are several such three dimensioz~rs spaces in use. One of these three dimensional spaces is the CTE 1931 (x, y)-chromaticity diagram (S~g Fig. 2). Luminosity, the third dimension, is not shown in Fig. 2. It is the trivariant nature of color vision that permits color to~be specified in a three dimensional space.
Another three dimensional space is represented in Figure 3. A plot is made of hue, :.
chroma and value and is shown as a three dimensional solid. These three numerical values can be used to specify any perceived color.
It is most important to note that although it is convenient to describe color in terms of a colorimetry, this is not color perception. Color SUBSTITUTE SHEET
iN0 94/02837 PCTIU$93/~6461 4 ~ , ._ ~1 perception is much more complex. However colorimetry is useful for color matching under s,~'ecific ,..
conditions. An analog of colorimetry, particularly ' one in the infrared region, would show similar .
usefulness in determining analyte.concentration.
There are commercially available colorimeters in the visible for measuring tristimulus y values in terms of luminosity, hue and saturation.
Briefly, these colorimeters use three detectors, with each detector input being filtered with a different filter function. Each of the filter functions is chosen to be similar to the three absorption spectra of the pigments of the three color receptive cones of the human retina. However, it appears no one has used, or even considered the use, of an analog of color perception for concentration measurements or even applied the method of colorimetry to infrared measurements as described herein.
Similarly, noninvasive measurement of arterial oxygen saturation by pua.se oximetry is widely acknowledged to be one of the most important technological advances in clinical patient , monitoring. Pulse oximeters measure differences in the visible and near infrared absorption spectra of ;
fully oxygenated and~reduced hemoglobin in arterial blood. Unlike clinical blood gas analyzers, which require a sample of blood from the patient and can only proqide intermittent measurement of patient oxygenation, pulse oximetry provide continuous, and instantaneous measurement of blood oxygen bevels.
~llBSTITUTE SHEET
-However, current commercial oximeters, and their algorithms are inaccurate under conditions of low pulse pressure and/or low oxygen saturation.
These severe conditions are observed in the normal unborn fetus. Unlike the transmission sampling of the commercial oaimeters. space limitations associated with the fetus require that the spectral data be obtained by reflectance sampling.
Reflectance sampling results in spectral data with a significantly lower signal-to-noise ratio than obtained with transmission sampling. It has been suggested that a new analysis technique using multivariate calibration methods can improve the precision, accuracy and reliability of quantitative spectral analysis. Even these techniques are limited by the type of input data.
Accordingly, an object to the invention is to provide an apparatus which provides an analog of colorimetric detection units so as to allow the measurements of the concentration of a constituent of interest.
Another object of the invention is to provide a method of measuring constituents of interest in a sample, preferably in a non-invasive manner, which is accurate, inexpensive and quick using an analog of a colorimetric analysis.
Another method of the invention is to provide a handheld instrument for glucose or drugs of abuse measurement based on the application of colorimetric type measurements to the near infrared region.
These and other objects and features will be apparent from the description and the accompanying drawings.
_ g _ Summarv of the Invention The present invention features an apparatus and method for the measurement of concentration of a constituent in a sample using reflectance or transmission, particularly in the near infrared. The apparatus and method of the present invention provide rapid, inexpensive measurements of high accuracy and are particularly adapted for non-invasive testing of the human body for constituents such as glucose or drugs of abuse.
In more detail, the invention provides an apparatus for measurement of the concentration of a constituent of interest which has absorbance or reflectance bands in the visible or near infrared spectrum. The constituent is in a sample which is illuminated by a light source that generates broad spectrum, preferably near infrared, radiation.
Although a single light source is preferred, in some embodiments multiple light sources can be used if the additive output of the light sources as a whole provides the requisite spectrum.
The apparatus also includes a sample chamber for holding the sample during measurement. The sample chamber can be arranged for non-invasive measurements of a portion of the human body such as a finger. The apparatus further includes detection means in the form of.a plurality of detector units.
Each detector unit is responsive to a specific region of the illuminating radiation or spectrum. Each of the detector units has at least partial non-parallel -_;.: W~ ~4/02~37 _ 214 p 2 3 9 PCT/US93/l16461 _ g _ overlapping regions of spectral response with at least one other of the detector units. In this manner, even in the region where the response of detector units overlap, each unit can provide some distinct information. The response from the detector units is the form of an output signal which is then transmitted to analysis means for combining and converting the output signal inta a measure of the concentration of the constituent of interest.
One key to the present invention is the realization that the detector units used should have a response to either transmitted or reflected radiation from the sample which is in a form of an analog of the color response of the eye. The response of the eye is in terms of red, green and blue sensors, the output of which are processed by the neural net in the eye and by the brain to provide the perception of color. The simplest approximation of color perception for certain specific conditions is colorimetry. A near infrareds analog of colorimetry, using infrared rather than visible radiation, is proposed herein, as are the use of colorimetry for concentration measurements and improved analysis methods. Accordingly, preferred embodiments of the invention have at least three detector units each having a spectral detection. range centered about a different portion of the selected spectrum but with response bands sufficiently wide that there is some overlap with at least one. and preferably more than one, other of the detector units. The detection means may also include a black/white or luminosity detector which is responsive to entire spectrum for which the other detector units have a spectral response. This SUBSTITUTE SHEET
~C3 94/02837 ~ ~ ~ PCT/US93/06461 ~' '°black/white" or luminosity detector, as used herein, is a detector like the other three that measures intensity of the signal photometrically in its spectral region of interest without perceiving the specificity of the wavelength,.~thereby showing the presence of a signal at one (or'',more) of the three other detectors.
The second step in complexity is to more closely approach color perception by using computational methods operating on the outputs of the detector units to emphasize the analyte with respect to the background. As a start, the computational models of color vision that have been developed in the field of "artificial intelligence" for attempting to achieve machine color vision will be utilized.
The third step towards approaching an analog of human color perception is to feed the detector unit outputs into an artificial neural net assembled similarly to the neural organization or circuitry of the retina and color portions in the brain. Here we expect to achieve learning for the detection, quantification, and in particular signal discrimination against background, with a smaller component cost and small size.
Neural networks, in the form of chips and other hardware, are presently available . Neural networks (or nets) provide processing which is similar to the brain (albeit on a less complicated scale) and, as such, can be "taught" to eliminate certain items of background.
The detector units can be selected to absorb only a particular broad band spectral region but more easily, standard silicon photocells can be used in conjunction with a series of broad bandpass filters.
SUBSTITUTE SHEET
. , W~ 94/0237 _ ~ 14 0 2 3 9 . PCT/US93/06461 i The term "broad bandpass infrared filters", as used herein, means filters that have a substantial half-width about a central wavelength, e.g., specified wavelengths in the near infrared region, so as to pass significant amounts of radiation far several hundred nm about the central wavelength. The use of broad bandpass filters allows significant response "tails" which overlap.
The apparatus can be adapted for detection of many substances. Preferred constituents of interest include glucose and drugs of abuse. "Drugs of abuse," as defined herein, include not just classic drugs of abuse such as marijuana, heroin,.
cocaine, amphetamines, barbiturates and other hallucinogenic or mind altering drugs, but also alcoho 1. For purposes of the invention, it does not matter whether the glucose or drug of abuse is measured directly but rather solely that the measurement of the sample can be correlated to the concentration of the constituent of interest. Far euample, it may be that the glucose is always correlated with the presence of a particular carrier or other indicating constituent and the carrier or constituent is measured in addition to and/or instead of the glucose itself.
The invention also features a method for measuring the concentration of a constituent of interest which absorbs or reflects light. The method has the steps of illuminating the sample with broadband spectrum, preferably near infrared, w radiation and detecting transmitted or reflected ;, .
iT ..
'a.
SUBSTITUTE SHEET
radiation from the sample. At least one signal corresponding to the detected radiation is generated and analyzed to determine the concentration of the constituent of interest. The detecting step of the method includes impinging radiation transmitted or reflected from the sample onto a detection array which includes a plurality of detector units each of which is responsive to a specific region of the near infrared spectrum. The specific spectral response from.each detector unit partially overlaps, in a non-parallel manner, the response from at least one other detector unit. Preferably, there are at least three detection units, each of which has a peak spectral response in a separate portion of the near infrared spectrum. The analysis step using this type of detection array allows analysis such that the output is formed into an analog of a colorimetric (e.g., tristimulus) value. The detector units may include broad bandpass filters to provide this spectral response and the detector array may also include a black/white detector unit such as has previously been described. In another aspect of the invention, the analysis may use an analog of a neural network, paralleling the working.of the eye and brain. This neural net based apparatus may even be used for classic colorimetry measurements.
The method of the invention is particularly well suited to non-invasive testing for constituent of the human body such as glucose, a glucose indicator or a drug of abuse. The finger is the preferred region for a sample for non-invasive testing.
;~'::'~'VO 94/02837 ~ i 4 0 2 3 9 . ' PCT/US93/06461 Another aspect of the invention is the use of paired detectors for referencing. In present non-invasive methods, there is na way to obtain a control reporting a "zero" concentration of the constituent of interest. However, by using a simulating filter o'r a filter made of the same material as the analyte but which has a concentration of the constituent of interest that is much higher than that in the sample, changing amounts of constituent in the sample merely cause a minor perturbation in the measurements from that "high concentration" reference detector. It may also be possible to use a material with substantially identical absorbance (or reflective) characteristics in place of the high concentration filter.
By using paired detectors with the "high concentration°' filter in front of one detector of the ' prior, one can obtain background measurements, unperturbed by the presence of the analyte to enhance discrimination. The term "paired detectors," as used herein means two or more detectors which are identical except for the high concentration filter.
For example, there could be paired red analog detectors, paired green analog detectors and paired v blue analog detectors, with the only difference being the addition of the high concentration filter to one of each pair. This type of high concentration filter is not limited to use with the apparatus and methods described'previously but has general applicability to any spectrophotometric system.
The following detailed description and the drawin will more clearl g y delineate the invention.
~;
;q :;
SUBSTITUTE SHEET
Wt? 94/02837 ~~~~t~ . .~ . PCf/US93/0646~
5...:' Brief Desrrip,~iQB of the Drawino Figure 1 is a spectrum for non-invasive glucose testing taken from United States Patent No.
5, 028, 787; ~.~'.;', Figure 2 is a CIE 1931 chromaticity plot;
Figure 3 is a three dimensional plot of color in terms of hue, chrome and value;
Figure 4 is a blue, green and red detector response vs. wavelength for a standard colorimeter, with a second scale of near infrared wavelengths as well as the visual wavelengths imposed on the X axis;
Figures 5A and 5B are variations of apparatus useful in the present invention; and Figure 6 is a detection array useful in the present invention.
Detailed Description of the Invention The present invention provides non-invasive procedures which can be used to test for glucose or other substances so long as the constituent of ' interest has absorption or reflectance bands in a selected, preferably,. near infrared, spectrum. The apparatus and methods of the invention are based in part, on the recognition that the present problems associated with attempting to conduct non-invasive measurements using near infrared radiation relate to ' the type of information which is obtained using spectrophotometers. Although using different analysis techniques can clarify what information has SUBSTITUTE SHEET
~...-r _ , . w ~' ~ . ,. , o~"., .~. . , , , .. .
_ a: WO 94/02837 _ 21 ~ ~ 2 ~ 9 PCT/U~93/Ob461 15 _ , been obtained, these analysis techniques cannot , generate optimum results if the underlying information obtained is itself not optimum. By J
applying an analog to colorimetry to concentration measurements , particularly forming a near infrared parallel of the three different pigments of the cones of the retina, significant information can be obtained which relates to concentration. Since in color perception "color constancy" is maintained under extreme variations in illumination, the use of neural~networks or digital computation to provide information in a manner more similar to the information processing of the eye-brain is preferred.
As noted previously, classic spectrophotometric methods for non-invasive measurements require the use of complex, and not altogether successful, data handling techniques in order to obtain meaningful information. Figure 1, which is a plot of wavelength versus 1/I intensity made using a scanning spectrophoi~ometer for a non-invasive determination of glucose. shows the problem with the classic techniques. First, the scan takes sufficient tame that there is the possibility of a change in the test conditions during the scan.
Second, while spectrophotometric measurements in the near infrared region are useful when there are high resolution features so that the substance of interest can be clearly discriminated from other substances, they do not work well unless the background and the features are separable. When glucose absorption bands are sought in the near infrared region, particularly using non-invasive techniques, only a SUBSTITUTE SHEET
few, low resolution features occur at the spectrum, such as that shown in Figure 1. This spectrum most resembles the spectrum of a colored object.
Figure 4 shows just such a color spectrum, with the red, green and blue detector responses of a colorimeter. The information determined from a colorimetric measurements is often used to determine the absolute color, and color differences of particular samples and their illuminants. Portable, inexpensive colorimeters are available in the market. For example, Minolta makes a series of tristimulus colorimeters including the Chroma meter xy-1 and Chroma meter CL-100. These tristimulus colorimeters may be used alone or attached to a data processor such as the Minolta DP-100 to express chromaticity readings in Yxy or Yu~v' systems, color difference readings in terms of G(Yxy) or ~(Yu'v').
luminescence, or black body temperature. These units can be used for either static or flickering light sources. Other instruments may be faster, i.e., give even more readings per second.
The Minolta colorimeters use silicon photocells which are filtered with red, green and blue broadpass filters. These filters cover a range from about 400-650 nm.
One aspect of the present invention utilizes this type of colorimeter with its filters replaced with filters having similar transmission and absorbance shapes but in the near infrared rather than visual region. 'The lower indices on the x-axis of Figure 4, those designated near infrared, can be used for guidelines for analogous transmission *Trade-mark spectra of filters for silicon photocells to obtain a spectral response in the near infrared rather than visual region. In this way, a near infrared equivalent to the tristimulus values could be constructed. With such information and sufficient standards, non-invasive measurements of constituent of interest such as glucose could be carried out in the near infrared region using substantially similar apparatus.
Figure 5A shows one type of apparatus particularly useful for non-invasive test of glucose using the methods of the present invention. A light source 10, which provides broad spectrum near infrared radiation (e.g., 700-1100 nm), is used for illumination. One possible light source is a tungsten-halogen bulb in a quartz envelope, filtered with a "heat shield" 20, if necessary, to provide only this wavelength range. A sample chamber 30 is shown for insertion of a finger or other bodily part if measurements are going to be made on a human or animal body. If a non-body sample is to be used, for ezample an agricultural sample, a different shaped sample chamber could be used in the same location.
The heat shield 20. which is optionally placed between lamp 10 and sample chamber 30, can be any material which will reduce the heat generated by the lamp 10 before if reaches sample chamber 30 without significantly degrading or absorbing the light generated from lamp 10 in its measurement region.
A detection array 40 is placed on the side of sample chamber 30 furthest from lamp 10 if a transmission mode is being utilized or off to the side of lamp 10 if a reflectance mode is being utilized.
WO 94I0~~37 PC'f/US93/0646j ~140~3~ -Source reference detectors 15 may be used to both measure the near infrared "color" of the source and guard against any changes in source output. In some embodiments. a paired detector array 40' and a special filter 50 may also°be used. Figure 5B shows the same apparatus as Figure 5A except the paired detectors are present. The illumination transmitted from sample chamber 30 goes to beam splitter 60 then either directly to detector array 40 or through filter 50 then to detector array 40'. Filter 50 is, preferably, a filter containing the same constituent of interest as is in the sample but in a concentration which is much (e.g., several order of.
magnitudes) higher. As such, filter 50 provides significant information concerning the background and the effective sample thickness since the amount of the constituent of interest in the sample acts merely as a negligible perturbation. This type of filter 50 is also useful for any other type of spectrophotometric analysis. The effective sample thickness or effective pathlength may also be corrected for by measuring the absorption of the sample in a wavelength region dominated by the absorption of the liquid carrier; e.g., water. The light reflected or transmitted from the sample is split into two output beams, a first output beam which is incident on a first detector responsive to the wavelength of the sample identifying bands, and the second'output beam which is incident on a second detector primarily responsive to liquid carrier absorption bands. This liquid carrier absorption .
measurement follows the same path as the sample indicating bands, yields an effective pathlength .
correction factor.
SUBSTITUTE SHEET
Figure 6 shows one type of detection array 40 which may be used in the present invention. This detection array has four detector units, three which are filtered in such a way that they have different peak spectral response but some partial overlap of spectral response while the fourth detector constitutes a black/white detector. This black/
white detector is responsive to all wavelengths in the infrared measurement region for which the other three detectors are responsive; that is, it generates an output signal responsive to wavelengths which cause a response for any of the three other detectors. As such, it acts like the rods of the retina of the eye.
The output from detector 40 (and detector 40' if used) is fed to analysis means 70. Analysis means 70 can be a computer, hardwired logic circuits, or a neural network. In any case, this analysis means 70 converts the output signal from the detectors to a measure of concentration.
Once the data from the detectors is obtained, it can be treated in a variety of ways. As noted previously, an analog of a colorimetric tristimulus value can be produced and calibrated against knowr. glucose concentrations. Problems that may arise with this simple type of data analysis is that calibration may be frequently required and may not be sufficiently universal, in that it will lack the analog of "color constancy" as do all colorimeters.
W~ 94/2837 . PCT/US93/06461 ~~~~,~~ - ~o -l3owever, the data analysis from the system, can be improved to more closely approach color .
perception by digital computation or with the use of neural networks (neural nets). While artificial-neural networks usually contain hundreds of interconnected neurons, this analog of color perception may only require about two dozen.
What this artificial neural act attempts to simulate are:
1. The horizontal cells, which transmit signals horizontally from the rods and cones to the bipolar cells.
2. The bipolar cells which transmit signals from the rods, cones and horizontal cells to synapse with either amacrine cells or ganglion cells.
3. The amacrine cells which transmit signals in two directions, either directly from bipolar cells to ganglion cells or horizontally among the axons of the bipolar cells, the dendrites of the ganglion cells, and/or other amacrine cells.
4. The ganglion cells which transmit output signals through the optic nerve to the brain.
5. The interplegiform cells which transmit ' signals in the retrograde direction from the inner plexiform layer to the outer plegiform layer. The i signals from these cells are all inhibitory.
6. Brain cells associated with "blobs"
which are believed to allow for color constancy. r 7. Brain cells which enable binocular fusion of colors. That is, when the fovea of one eye is stimulated by homogenous red light and the fovea ' , WO 94/02837 214 0 ~ 3 9 PC'T/US93/06461 'w, - 21 - , of the other eye is stimulated by homogenous green light, the resultant binocular impression is the same . ;
as that of seeing yellow.
The most important factor of using a neural ;
network is the learning capacity of the network.
Since the neural network can '°learn", it may be calibrated a single time for the individual, or even have a universal calibration at the factory, and still give consistent results over time. Learning in a neural net context is provided by a change in the way of connections run from one °'neuron" to another.
The foregoing description invention is ms:ant to be explanatory only and not intended to be limited to the scope of the invention. The invention is defined by the following claims.
What is claimed is:
w SUBSTITUTE SHEET
which are believed to allow for color constancy. r 7. Brain cells which enable binocular fusion of colors. That is, when the fovea of one eye is stimulated by homogenous red light and the fovea ' , WO 94/02837 214 0 ~ 3 9 PC'T/US93/06461 'w, - 21 - , of the other eye is stimulated by homogenous green light, the resultant binocular impression is the same . ;
as that of seeing yellow.
The most important factor of using a neural ;
network is the learning capacity of the network.
Since the neural network can '°learn", it may be calibrated a single time for the individual, or even have a universal calibration at the factory, and still give consistent results over time. Learning in a neural net context is provided by a change in the way of connections run from one °'neuron" to another.
The foregoing description invention is ms:ant to be explanatory only and not intended to be limited to the scope of the invention. The invention is defined by the following claims.
What is claimed is:
w SUBSTITUTE SHEET
Claims (29)
1. An apparatus determining the concentration in a sample of a constituent of interest which has absorption or reflectance bands in a selected region of the spectrum comprising:
a light source that illuminates said sample with broad spectrum radiation in said selected region;
a sample chamber for confining said sample during said illumination;
detection means in the form of a plurality of detector units, each of said detector units being responsive to a specific region of said spectrum and having a partial overlapping region of spectral response with another of said detector units, said response from each detector unit being in the form of an output signal; and analysis means for converting said output signals into a measure of said concentration.
a light source that illuminates said sample with broad spectrum radiation in said selected region;
a sample chamber for confining said sample during said illumination;
detection means in the form of a plurality of detector units, each of said detector units being responsive to a specific region of said spectrum and having a partial overlapping region of spectral response with another of said detector units, said response from each detector unit being in the form of an output signal; and analysis means for converting said output signals into a measure of said concentration.
2. The apparatus of claim 1 wherein said selected region of said spectrum is the near infrared region.
3. The apparatus of claim 1 when said detector means comprises at least three detector units each having a spectral response region centered about a different portion of said spectrum.
4. The apparatus of claim 3 wherein said detector units each generate signals that are near infrared analogs of the color receptive elements in vision.
5. The apparatus of claim 4 wherein said analysis means generates an output which is a near infrared analog of a location in a colorimetric three dimensional space.
6. The apparatus of claim 3 wherein said detection means further comprises a black/white luminosity detector which is responsive to and overlaps the near infrared spectral response of said detector units.
7. The apparatus of claim 1 wherein said analysis means comprises an artificial neural network.
8. The apparatus of claim 1 wherein each of said detector units comprises broad bandpass filters.
9. The apparatus of claim 1 wherein said detector units comprise silicon photocells.
10. The apparatus of claim 1 wherein said sample chamber is arranged for non-invasive measurements on a portion of a human body.
11. The apparatus of claim 10 wherein said human body portion comprises a finger.
12. The apparatus of claim 10 wherein said constituent of interest is selected from the group consisting of glucose, and glucose indicating constituents.
13. The apparatus of claim 11 wherein said constituent of interest is selected from the group consisting of drugs of abuse, and drugs of abuse indicating constituents.
14. The apparatus of claim 1 further comprising a filter unit which has an absorption at the same spectral bands of said constituent of interest, the absorption of said filter unit corresponding to at least one order of magnitude greater concentration than the response of said constituent of interest.
15. The apparatus of claim 14 wherein said filter unit comprises a high concentration solution of said constituent of interest.
16. A method for measuring the concentration in a sample of a constituent of interest which absorbs or reflects light, said method comprising the steps of:
illuminating said sample with broad spectrum radiation;
detecting transmitted or reflected radiation from said sample;
generating at least one signal corresponding to said detected radiation; and analyzing said signal to measure the concentration of said constituent;
wherein said detecting step includes impinging the radiation transmitted or reflected from said sample onto a detection array which generates said signal, said detection array including a plurality of detector units each responsive to a specific region of the transmitted or reflected spectrum, the spectral response of each of said detector units having at least partial overlap with the response of at least one other of said detector units.
illuminating said sample with broad spectrum radiation;
detecting transmitted or reflected radiation from said sample;
generating at least one signal corresponding to said detected radiation; and analyzing said signal to measure the concentration of said constituent;
wherein said detecting step includes impinging the radiation transmitted or reflected from said sample onto a detection array which generates said signal, said detection array including a plurality of detector units each responsive to a specific region of the transmitted or reflected spectrum, the spectral response of each of said detector units having at least partial overlap with the response of at least one other of said detector units.
17. The method of claim 16 wherein at least three detection units are used in said detecting step, each detector unit having a peak spectral response in a separate portion of said spectrum.
18. The method of claim 17 wherein said analysis step comprises forming from the output a near infrared analog of a specific position in a three dimension colorimetric space.
19. The method of claim 16 wherein said detector units comprise broad bandpass filters.
20. The method of claim 16 wherein said detecting step further comprises the use of a black/white detector unit which is responsive to the entire spectrum for which said detector units have a spectral response.
21. The method of claim 16 wherein said analysis step comprises utilizing an artificial analog of a neural network.
22. The method of claim 21 wherein said artificial neural network is calibrated and trained to process said signals to achieve an analog of color constancy in vision.
23. The method of claim 16 wherein said method is used for non-invasive testing for a constituent in a human body.
24. The method of claim 23 wherein said constituent is selected from the group consisting of glucose and glucose indicating constituents.
25. The method of claim 23 wherein said constituent is selected from the group consisting of drugs of abuse and drugs of abuse indicating constituents.
26. The method of claim 23 wherein said sample comprises a finger.
27. An apparatus to perform colorimetry using absorption of reflectance in a selected region of the spectrum comprising:
a light source that generates broad spectrum radiation in said selected region;
detection means in the form of a plurality of detector units, each of said detector units being responsive to a specific region of said spectrum and having a partial overlapping region of spectral response with another of said detector units, said response from each detector unit being in the form of an output signal; and analysis means in the form of a neural net for converting said output signals into colorimetry values.
a light source that generates broad spectrum radiation in said selected region;
detection means in the form of a plurality of detector units, each of said detector units being responsive to a specific region of said spectrum and having a partial overlapping region of spectral response with another of said detector units, said response from each detector unit being in the form of an output signal; and analysis means in the form of a neural net for converting said output signals into colorimetry values.
28. A method for colorimetric measures using transmittance or reflectance measurements comprising the steps of:
illuminating a sample with broad spectrum radiation;
detecting transmitted or reflected radiation from said sample;
generating at least one signal corresponding to said detected radiation; and analyzing said signal to measure the concentration of said constituent;
wherein said detecting step includes impinging the radiation transmitted or reflected from said sample onto a detection array which generates said signal, said detection array including a plurality of detector units each responsive to a specific region of the transmitted or reflected spectrum, the spectral response of each of said detector units having at lest partial overlap with the response of at least one other of said detector units;
and said analysis step is carried out using a neural net.
illuminating a sample with broad spectrum radiation;
detecting transmitted or reflected radiation from said sample;
generating at least one signal corresponding to said detected radiation; and analyzing said signal to measure the concentration of said constituent;
wherein said detecting step includes impinging the radiation transmitted or reflected from said sample onto a detection array which generates said signal, said detection array including a plurality of detector units each responsive to a specific region of the transmitted or reflected spectrum, the spectral response of each of said detector units having at lest partial overlap with the response of at least one other of said detector units;
and said analysis step is carried out using a neural net.
29. The method of claim 28 wherein said method is used to achieve substantial color constancy.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/914,265 US5321265A (en) | 1992-07-15 | 1992-07-15 | Non-invasive testing |
US914,265 | 1992-07-15 | ||
PCT/US1993/006461 WO1994002837A1 (en) | 1992-07-15 | 1993-07-08 | Non-invasive testing |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2140239A1 CA2140239A1 (en) | 1994-02-03 |
CA2140239C true CA2140239C (en) | 2005-06-28 |
Family
ID=25434103
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002140239A Expired - Fee Related CA2140239C (en) | 1992-07-15 | 1993-07-08 | Non-invasive testing |
Country Status (8)
Country | Link |
---|---|
US (1) | US5321265A (en) |
EP (2) | EP0967478A1 (en) |
JP (1) | JPH08502350A (en) |
AU (1) | AU4670293A (en) |
CA (1) | CA2140239C (en) |
DE (1) | DE69328363T2 (en) |
ES (1) | ES2146232T3 (en) |
WO (1) | WO1994002837A1 (en) |
Families Citing this family (101)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6420709B1 (en) | 1992-07-15 | 2002-07-16 | Optix Lp | Methods of minimizing scattering and improving tissue sampling in non-invasive testing and imaging |
US6222189B1 (en) | 1992-07-15 | 2001-04-24 | Optix, Lp | Methods of enhancing optical signals by mechanical manipulation in non-invasive testing |
US6411832B1 (en) | 1992-07-15 | 2002-06-25 | Optix Lp | Method of improving reproducibility of non-invasive measurements |
US5424545A (en) * | 1992-07-15 | 1995-06-13 | Myron J. Block | Non-invasive non-spectrophotometric infrared measurement of blood analyte concentrations |
US5434412A (en) * | 1992-07-15 | 1995-07-18 | Myron J. Block | Non-spectrophotometric measurement of analyte concentrations and optical properties of objects |
US5818048A (en) * | 1992-07-15 | 1998-10-06 | Optix Lp | Rapid non-invasive optical analysis using broad bandpass spectral processing |
US5672875A (en) * | 1992-07-15 | 1997-09-30 | Optix Lp | Methods of minimizing scattering and improving tissue sampling in non-invasive testing and imaging |
DE4339067A1 (en) * | 1993-11-16 | 1995-05-18 | Jenoptik Jena Gmbh | Method and arrangement for the non-invasive, transcutaneous determination of substance concentrations in body fluid or human tissue |
US5459317A (en) * | 1994-02-14 | 1995-10-17 | Ohio University | Method and apparatus for non-invasive detection of physiological chemicals, particularly glucose |
US5477326A (en) * | 1994-06-30 | 1995-12-19 | Bayer Corporation | Spectrophotometer arrangement with multi-detector readhead |
US5553613A (en) * | 1994-08-17 | 1996-09-10 | Pfizer Inc. | Non invasive blood analyte sensor |
US5803909A (en) * | 1994-10-06 | 1998-09-08 | Hitachi, Ltd. | Optical system for measuring metabolism in a body and imaging method |
SG38866A1 (en) * | 1995-07-31 | 1997-04-17 | Instrumentation Metrics Inc | Liquid correlation spectrometry |
US6152876A (en) | 1997-04-18 | 2000-11-28 | Rio Grande Medical Technologies, Inc. | Method for non-invasive blood analyte measurement with improved optical interface |
US6240306B1 (en) | 1995-08-09 | 2001-05-29 | Rio Grande Medical Technologies, Inc. | Method and apparatus for non-invasive blood analyte measurement with fluid compartment equilibration |
US5655530A (en) * | 1995-08-09 | 1997-08-12 | Rio Grande Medical Technologies, Inc. | Method for non-invasive blood analyte measurement with improved optical interface |
US6212424B1 (en) | 1998-10-29 | 2001-04-03 | Rio Grande Medical Technologies, Inc. | Apparatus and method for determination of the adequacy of dialysis by non-invasive near-infrared spectroscopy |
US6240309B1 (en) * | 1995-10-06 | 2001-05-29 | Hitachi, Ltd. | Optical measurement instrument for living body |
US20060184047A1 (en) * | 1995-11-17 | 2006-08-17 | Yuichi Yamashita | Optical measurement instrument for living body |
US5748308A (en) * | 1996-02-02 | 1998-05-05 | Abbott Laboratories | Programmable standard for use in an apparatus and process for the noninvasive measurement of optically absorbing compounds |
US5788632A (en) * | 1996-03-19 | 1998-08-04 | Abbott Laboratories | Apparatus and process for the non-invasive measurement of optically active compounds |
US5961451A (en) * | 1997-04-07 | 1999-10-05 | Motorola, Inc. | Noninvasive apparatus having a retaining member to retain a removable biosensor |
US7890158B2 (en) * | 2001-06-05 | 2011-02-15 | Lumidigm, Inc. | Apparatus and method of biometric determination using specialized optical spectroscopy systems |
US6628809B1 (en) | 1999-10-08 | 2003-09-30 | Lumidigm, Inc. | Apparatus and method for identification of individuals by near-infrared spectrum |
US6560352B2 (en) | 1999-10-08 | 2003-05-06 | Lumidigm, Inc. | Apparatus and method of biometric identification or verification of individuals using optical spectroscopy |
US6246893B1 (en) * | 1997-06-12 | 2001-06-12 | Tecmed Incorporated | Method and device for glucose concentration measurement with special attention to blood glucose determinations |
US6043492A (en) * | 1997-10-27 | 2000-03-28 | Industrial Technology Research Institute | Non-invasive blood glucose meter |
US6070093A (en) | 1997-12-02 | 2000-05-30 | Abbott Laboratories | Multiplex sensor and method of use |
US6002953A (en) * | 1998-05-06 | 1999-12-14 | Optix Lp | Non-invasive IR transmission measurement of analyte in the tympanic membrane |
US6662030B2 (en) | 1998-05-18 | 2003-12-09 | Abbott Laboratories | Non-invasive sensor having controllable temperature feature |
US7043287B1 (en) | 1998-05-18 | 2006-05-09 | Abbott Laboratories | Method for modulating light penetration depth in tissue and diagnostic applications using same |
US6526298B1 (en) | 1998-05-18 | 2003-02-25 | Abbott Laboratories | Method for the non-invasive determination of analytes in a selected volume of tissue |
US6241663B1 (en) | 1998-05-18 | 2001-06-05 | Abbott Laboratories | Method for improving non-invasive determination of the concentration of analytes in a biological sample |
US6662031B1 (en) | 1998-05-18 | 2003-12-09 | Abbott Laboratoies | Method and device for the noninvasive determination of hemoglobin and hematocrit |
SE512098C2 (en) | 1998-05-19 | 2000-01-24 | Agrovision Ab | Concentration determination of one component in a mixture of at least two components |
US7098037B2 (en) | 1998-10-13 | 2006-08-29 | Inlight Solutions, Inc. | Accommodating subject and instrument variations in spectroscopic determinations |
US6157041A (en) | 1998-10-13 | 2000-12-05 | Rio Grande Medical Technologies, Inc. | Methods and apparatus for tailoring spectroscopic calibration models |
US6441388B1 (en) | 1998-10-13 | 2002-08-27 | Rio Grande Medical Technologies, Inc. | Methods and apparatus for spectroscopic calibration model transfer |
US6370407B1 (en) | 1999-07-27 | 2002-04-09 | Tecmed, Incorporated | System for improving the sensitivity and stability of optical polarimetric measurements |
US6919566B1 (en) * | 1999-08-31 | 2005-07-19 | Nir Diagnostics Inc. | Method of calibrating a spectroscopic device |
US6816605B2 (en) | 1999-10-08 | 2004-11-09 | Lumidigm, Inc. | Methods and systems for biometric identification of individuals using linear optical spectroscopy |
US6452180B1 (en) | 2000-03-28 | 2002-09-17 | Advanced Micro Devices, Inc. | Infrared inspection for determining residual films on semiconductor devices |
US6862091B2 (en) | 2001-04-11 | 2005-03-01 | Inlight Solutions, Inc. | Illumination device and method for spectroscopic analysis |
US6574490B2 (en) | 2001-04-11 | 2003-06-03 | Rio Grande Medical Technologies, Inc. | System for non-invasive measurement of glucose in humans |
US7126682B2 (en) * | 2001-04-11 | 2006-10-24 | Rio Grande Medical Technologies, Inc. | Encoded variable filter spectrometer |
US6865408B1 (en) | 2001-04-11 | 2005-03-08 | Inlight Solutions, Inc. | System for non-invasive measurement of glucose in humans |
US6983176B2 (en) | 2001-04-11 | 2006-01-03 | Rio Grande Medical Technologies, Inc. | Optically similar reference samples and related methods for multivariate calibration models used in optical spectroscopy |
US7167734B2 (en) | 2001-04-13 | 2007-01-23 | Abbott Laboratories | Method for optical measurements of tissue to determine disease state or concentration of an analyte |
CA2445680A1 (en) * | 2001-05-02 | 2002-11-07 | Csir | Spectrometry using broadand filters with overlapping spectral ranges |
US20040147034A1 (en) * | 2001-08-14 | 2004-07-29 | Gore Jay Prabhakar | Method and apparatus for measuring a substance in a biological sample |
EP1428013A4 (en) * | 2001-08-14 | 2007-10-31 | Purdue Research Foundation | Measuring a substance in a biological sample |
US7027848B2 (en) | 2002-04-04 | 2006-04-11 | Inlight Solutions, Inc. | Apparatus and method for non-invasive spectroscopic measurement of analytes in tissue using a matched reference analyte |
US6752846B2 (en) * | 2002-07-18 | 2004-06-22 | Kohler Co. | Panel type air filter element with integral baffle |
US7288768B2 (en) * | 2002-07-18 | 2007-10-30 | Purdue Research Foundation | Method for measuring the amount of an organic substance in a food product with infrared electromagnetic radiation |
GB2391305B (en) * | 2002-07-25 | 2007-02-14 | Hewlett Packard Co | Colour sensing apparatus and methods |
US7620212B1 (en) | 2002-08-13 | 2009-11-17 | Lumidigm, Inc. | Electro-optical sensor |
EP1464273B1 (en) * | 2003-04-03 | 2006-11-29 | Matsushita Electric Industrial Co., Ltd. | Method and device for measuring concentration of specific component |
US7347365B2 (en) * | 2003-04-04 | 2008-03-25 | Lumidigm, Inc. | Combined total-internal-reflectance and tissue imaging systems and methods |
US7545963B2 (en) | 2003-04-04 | 2009-06-09 | Lumidigm, Inc. | Texture-biometrics sensor |
US7539330B2 (en) | 2004-06-01 | 2009-05-26 | Lumidigm, Inc. | Multispectral liveness determination |
US7460696B2 (en) | 2004-06-01 | 2008-12-02 | Lumidigm, Inc. | Multispectral imaging biometrics |
US7627151B2 (en) * | 2003-04-04 | 2009-12-01 | Lumidigm, Inc. | Systems and methods for improved biometric feature definition |
DE602004030549D1 (en) | 2003-04-04 | 2011-01-27 | Lumidigm Inc | MULTISPEKTRALBIOMETRIESENSOR |
US7394919B2 (en) | 2004-06-01 | 2008-07-01 | Lumidigm, Inc. | Multispectral biometric imaging |
US7668350B2 (en) | 2003-04-04 | 2010-02-23 | Lumidigm, Inc. | Comparative texture analysis of tissue for biometric spoof detection |
US7751594B2 (en) | 2003-04-04 | 2010-07-06 | Lumidigm, Inc. | White-light spectral biometric sensors |
US7092101B2 (en) * | 2003-04-16 | 2006-08-15 | Duke University | Methods and systems for static multimode multiplex spectroscopy |
US6975892B2 (en) * | 2003-10-21 | 2005-12-13 | Oculir, Inc. | Methods for non-invasive analyte measurement from the conjunctiva |
US6968222B2 (en) | 2003-05-02 | 2005-11-22 | Oculir, Inc. | Methods and device for non-invasive analyte measurement |
US6958039B2 (en) * | 2003-05-02 | 2005-10-25 | Oculir, Inc. | Method and instruments for non-invasive analyte measurement |
US6992772B2 (en) * | 2003-06-19 | 2006-01-31 | Optix Lp | Method and apparatus for optical sampling to reduce interfering variances |
US20050007582A1 (en) * | 2003-07-07 | 2005-01-13 | Lumidigm, Inc. | Methods and apparatus for collection of optical reference measurements for monolithic sensors |
US7263213B2 (en) | 2003-12-11 | 2007-08-28 | Lumidigm, Inc. | Methods and systems for estimation of personal characteristics from biometric measurements |
US20080009688A1 (en) * | 2004-04-14 | 2008-01-10 | Oculir, Inc. | Methods for non-invasive analyte measurement |
US20060258919A1 (en) * | 2004-04-14 | 2006-11-16 | Oculir, Inc. | Non-Invasive Analyte Measurement Device for Measuring Tears and Other Ocular Elements Using Electromagnetic Radiation and Method of Using the Same |
US20110163163A1 (en) * | 2004-06-01 | 2011-07-07 | Lumidigm, Inc. | Multispectral barcode imaging |
US7508965B2 (en) | 2004-06-01 | 2009-03-24 | Lumidigm, Inc. | System and method for robust fingerprint acquisition |
US8229185B2 (en) | 2004-06-01 | 2012-07-24 | Lumidigm, Inc. | Hygienic biometric sensors |
US8787630B2 (en) | 2004-08-11 | 2014-07-22 | Lumidigm, Inc. | Multispectral barcode imaging |
US8335550B2 (en) * | 2005-03-25 | 2012-12-18 | Cnoga Holdings Ltd. | Optical sensor device and image processing unit for measuring chemical concentrations, chemical saturations and biophysical parameters |
US7801338B2 (en) | 2005-04-27 | 2010-09-21 | Lumidigm, Inc. | Multispectral biometric sensors |
DE102006002500B4 (en) * | 2006-01-13 | 2008-02-28 | Hottinger Baldwin Messtechnik Gmbh | Optical spectrometer |
US8175346B2 (en) | 2006-07-19 | 2012-05-08 | Lumidigm, Inc. | Whole-hand multispectral biometric imaging |
US7899217B2 (en) | 2006-07-19 | 2011-03-01 | Lumidign, Inc. | Multibiometric multispectral imager |
US7995808B2 (en) | 2006-07-19 | 2011-08-09 | Lumidigm, Inc. | Contactless multispectral biometric capture |
US8355545B2 (en) | 2007-04-10 | 2013-01-15 | Lumidigm, Inc. | Biometric detection using spatial, temporal, and/or spectral techniques |
US7801339B2 (en) | 2006-07-31 | 2010-09-21 | Lumidigm, Inc. | Biometrics with spatiospectral spoof detection |
US7804984B2 (en) | 2006-07-31 | 2010-09-28 | Lumidigm, Inc. | Spatial-spectral fingerprint spoof detection |
US20080144005A1 (en) * | 2006-12-19 | 2008-06-19 | Cytyc Corporation | Method for analyzing blood content of cytological specimens |
US8285010B2 (en) | 2007-03-21 | 2012-10-09 | Lumidigm, Inc. | Biometrics based on locally consistent features |
US20090155919A1 (en) * | 2007-12-17 | 2009-06-18 | Optix, Llp | High throughput drug screening method |
US8274565B2 (en) * | 2008-12-31 | 2012-09-25 | Iscon Video Imaging, Inc. | Systems and methods for concealed object detection |
CN102460157B (en) | 2009-05-22 | 2014-05-28 | 3M创新有限公司 | Multilayer colorimetric sensor arrays |
WO2011028620A1 (en) | 2009-08-26 | 2011-03-10 | Lumidigm, Inc. | Multiplexed biometric imaging and dual-imager biometric sensor |
US8570149B2 (en) | 2010-03-16 | 2013-10-29 | Lumidigm, Inc. | Biometric imaging using an optical adaptive interface |
US8694067B2 (en) * | 2011-02-15 | 2014-04-08 | General Electric Company | Sensor, apparatus and method for non-invasively monitoring blood characteristics of a subject |
WO2016054079A1 (en) | 2014-09-29 | 2016-04-07 | Zyomed Corp. | Systems and methods for blood glucose and other analyte detection and measurement using collision computing |
US9554738B1 (en) | 2016-03-30 | 2017-01-31 | Zyomed Corp. | Spectroscopic tomography systems and methods for noninvasive detection and measurement of analytes using collision computing |
US20180098733A1 (en) * | 2016-08-31 | 2018-04-12 | Medika Healthcare Co., Ltd. | Non-invasive glucose monitoring system |
CN110680341B (en) * | 2019-10-25 | 2021-05-18 | 北京理工大学 | Non-invasive blood sugar detection device based on visible light image |
TWI758891B (en) * | 2020-09-30 | 2022-03-21 | 國立成功大學 | System and method for sensing concentration |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3569721A (en) * | 1969-01-13 | 1971-03-09 | American Optical Corp | Measuring bilirubin in blood using light at two wavelengths |
US4278538A (en) * | 1979-04-10 | 1981-07-14 | Western Electric Company, Inc. | Methods and apparatus for sorting workpieces according to their color signature |
DE3137658C2 (en) * | 1981-09-22 | 1985-06-05 | H. Maihak Ag, 2000 Hamburg | Device for measuring the concentration of an IR, NIR, VIS or UV radiation absorbing gas in a gas matrix |
US4520265A (en) * | 1983-09-06 | 1985-05-28 | Southern California Gas Co. | Method and apparatus for accurate remote monitoring of gases |
US4543481A (en) * | 1983-12-08 | 1985-09-24 | Moniteq Ltd. | Leak detection in pipelines |
SU1187032A1 (en) * | 1984-01-04 | 1985-10-23 | Предприятие П/Я Р-6711 | Method of determining content of benzene hydrocarbon in petroleum products |
DD233873A1 (en) * | 1984-08-08 | 1986-03-12 | Adl Inst Phytopathologie | MEASURING DEVICE FOR IDENTIFYING DIFFERENTLY FLACED ELEMENTS |
US4882492A (en) * | 1988-01-19 | 1989-11-21 | Biotronics Associates, Inc. | Non-invasive near infrared measurement of blood analyte concentrations |
JPH02164341A (en) * | 1988-12-19 | 1990-06-25 | Nippon Koden Corp | Hemoglobin concentration measuring device |
US5028787A (en) * | 1989-01-19 | 1991-07-02 | Futrex, Inc. | Non-invasive measurement of blood glucose |
-
1992
- 1992-07-15 US US07/914,265 patent/US5321265A/en not_active Expired - Lifetime
-
1993
- 1993-07-08 JP JP6504507A patent/JPH08502350A/en active Pending
- 1993-07-08 EP EP99202777A patent/EP0967478A1/en not_active Withdrawn
- 1993-07-08 EP EP93917056A patent/EP0650591B1/en not_active Expired - Lifetime
- 1993-07-08 ES ES93917056T patent/ES2146232T3/en not_active Expired - Lifetime
- 1993-07-08 CA CA002140239A patent/CA2140239C/en not_active Expired - Fee Related
- 1993-07-08 AU AU46702/93A patent/AU4670293A/en not_active Abandoned
- 1993-07-08 WO PCT/US1993/006461 patent/WO1994002837A1/en active IP Right Grant
- 1993-07-08 DE DE69328363T patent/DE69328363T2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE69328363T2 (en) | 2000-08-10 |
WO1994002837A1 (en) | 1994-02-03 |
ES2146232T3 (en) | 2000-08-01 |
DE69328363D1 (en) | 2000-05-18 |
EP0650591B1 (en) | 2000-04-12 |
US5321265A (en) | 1994-06-14 |
CA2140239A1 (en) | 1994-02-03 |
EP0650591A1 (en) | 1995-05-03 |
EP0967478A1 (en) | 1999-12-29 |
JPH08502350A (en) | 1996-03-12 |
EP0650591A4 (en) | 1995-11-08 |
AU4670293A (en) | 1994-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2140239C (en) | Non-invasive testing | |
KR100314296B1 (en) | Non-spectrophotometric apparatus and method for measuring the concentration and optical properties of the object | |
EP0742897B1 (en) | Non-invasive non-spectrophotometric infrared measurement of blood analyte concentrations | |
US6028311A (en) | Rapid non-invasive optical analysis using broad bandpass spectral processing | |
US5218207A (en) | Using led harmonic wavelengths for near-infrared quantitative | |
US5086229A (en) | Non-invasive measurement of blood glucose | |
US5725480A (en) | Non-invasive calibration and categorization of individuals for subsequent non-invasive detection of biological compounds | |
WO1996013202A1 (en) | Non-invasive determination of analyte concentration in body of mammals | |
HU216847B (en) | Method and arrangement for prompt non-invasive determination of blood parameters | |
US6615151B1 (en) | Method for creating spectral instrument variation tolerance in calibration algorithms | |
KR19990022569A (en) | Method and apparatus for detecting and measuring the condition affecting color | |
Domján et al. | Rapid analysis of whole blood and blood serum using near infrared spectroscopy | |
US6801316B2 (en) | Measurement of an analyte concentration in a scattering medium | |
CN111803085A (en) | Noninvasive hemoglobin concentration level measuring device based on color characteristics | |
Cohen et al. | Paper Session II-B-Optical Diagnostics: Reagentless Chemistry for Extended Space Flights |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |